Laetiporus sulphureus polysaccharides mitigate colitis by reshaping the gut microbiota and regulating immune responses
Frontiers in Pharmacology · 15.04.2026 · 17
DOI: 10.3389/fphar.2026.1705032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 15.04.2026. Verfasst von Sharafat Ali und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, College of Basic Medical Science, Dalian Medical University, Dalian, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Inflammatory bowel disease (IBD) involves epithelial barrier disruption, immune dysregulation, and microbial imbalance. The present study investigated the protective mechanisms of Laetiporus sulphureus polysaccharides (LSP) in dextran sulfate sodium (DSS)-induced colitis, focusing on intestinal barrier restoration, immunomodulation, and gut microbiota remodeling.
Methods
LSP was structurally characterized using HPLC, FTIR, and SEM analyses, revealing a heteropolysaccharide primarily composed of glucose (55.16%), galactose (16.55%), and mannose (13.52%). Experimental colitis was induced in BALB/c mice with 3% DSS, followed by oral LSP administration (200 or 400 mg/kg). Disease severity, histopathology, barrier markers, cytokine profiles, macrophage polarization, and gut microbiota composition were evaluated using biochemical assays, immunofluorescence, IHC, and 16S rRNA sequencing.
Results
LSP significantly mitigated DSS-induced colitis by reducing the disease activity index by approximately 60% (∼2.5-fold, p < 0.001) and restoring colon length (∼1.5-fold, p < 0.01). Barrier integrity improved via enhanced mucin-2 expression (∼3.5-fold) and tight junction proteins Occludin, Claudin-1, and ZO-1 (∼5–9-fold). LSP suppressed pro-inflammatory cytokines TNF-α, IL-6, and IL-1β (∼2–3-fold) while upregulating anti-inflammatory mediators IL-10 and TGF-β (∼2.5–3-fold), reflecting a rebalanced mucosal immune milieu. 16S rRNA sequencing demonstrated reversal of DSS-induced dysbiosis, characterized by a reduction in pathogenic Escherichia–Shigella (∼3.8-fold) and Enterobacteriaceae (∼3.5-fold), and enrichment of beneficial taxa including Lactobacillus , Bifidobacterium, and Ruminococcus (∼2–4-fold).
Conclusion
LSP exerts multi-targeted protection against colitis by reinforcing epithelial barrier function, attenuating inflammation, and reshaping gut microbial ecology. These findings highlight LSP as a promising natural therapeutic candidate for IBD. Further metabolomic and meta transcriptomic analyses are warranted to elucidate the microbial metabolites and molecular pathways mediating these protective effects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, College of Basic Medical Science, Dalian Medical University, Dalian, China.
- Department of Biotechnology, College of Basic Medical Science, Dalian Medical University, Dalian, China.
- Department of Microecology, College of Basic Medical Science, Dalian Medical University, Dalian, China.
- Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, and School of Pharmacy, Guangdong Medical University, Dongguan, China.
- Department of Physiology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China.
Zitieren
APA
Ali, S., Alioui, Y., Khan, I., Ullah, H., Rahman, M. U., Atta, A., Abusidu, M., Ilyas, M., Noor, U., Ma, R., Ali, M., Farooqui, N. A., Deng, T., Wang, G., Xin, Y., Sha, S., & Ma, Y. (2026). Laetiporus sulphureus polysaccharides mitigate colitis by reshaping the gut microbiota and regulating immune responses. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1705032
Vancouver
Ali S, Alioui Y, Khan I, Ullah H, Rahman MU, Atta A, et al. Laetiporus sulphureus polysaccharides mitigate colitis by reshaping the gut microbiota and regulating immune responses. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1705032
BibTeX
@article{Ali2026,
author = {Ali, Sharafat and Alioui, Yamina and Khan, Imran and Ullah, Hidayat and Rahman, Mujeeb Ur and Atta, Aamna and Abusidu, Mohammed and Ilyas, Muhammad and Noor, Uzma and Ma, Renzhen and Ali, Muhsin and Farooqui, Nabeel Ahmed and Deng, Ting and Wang, Guangyang and Xin, Yi and Sha, Shanshan and Ma, Yufang},
title = {Laetiporus sulphureus polysaccharides mitigate colitis by reshaping the gut microbiota and regulating immune responses},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1705032}
}
EUVIMED